Merit Medical Systems (NASDAQ:MMSI) Updates FY 2025 Earnings Guidance

Merit Medical Systems (NASDAQ:MMSI) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 3.580-3.700 for the period, compared to the consensus estimate of 3.740. The company issued revenue guidance of $1.5 billion-$1.5 billion, compared to the consensus revenue estimate of $1.5 billion.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on MMSI. Raymond James boosted their target price on shares of Merit Medical Systems from $105.00 to $110.00 and gave the stock an “outperform” rating in a report on Tuesday, December 31st. Canaccord Genuity Group dropped their target price on Merit Medical Systems from $128.00 to $127.00 and set a “buy” rating on the stock in a research report on Wednesday. Wells Fargo & Company reduced their target price on shares of Merit Medical Systems from $120.00 to $117.00 and set an “overweight” rating on the stock in a research report on Wednesday. Needham & Company LLC lowered their price target on Merit Medical Systems from $122.00 to $116.00 and set a “buy” rating on the stock in a report on Wednesday. Finally, Robert W. Baird lifted their price target on shares of Merit Medical Systems from $107.00 to $109.00 and gave the stock an “outperform” rating in a research note on Thursday, October 31st. Two investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $108.80.

Merit Medical Systems Stock Down 1.2 %

Shares of NASDAQ MMSI traded down $1.26 during midday trading on Wednesday, hitting $100.77. The company’s stock had a trading volume of 635,820 shares, compared to its average volume of 519,410. The business’s fifty day simple moving average is $102.72 and its two-hundred day simple moving average is $99.89. The company has a debt-to-equity ratio of 0.57, a current ratio of 5.36 and a quick ratio of 3.82. The firm has a market capitalization of $5.87 billion, a price-to-earnings ratio of 49.29, a price-to-earnings-growth ratio of 2.34 and a beta of 0.87. Merit Medical Systems has a 1 year low of $70.70 and a 1 year high of $111.45.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.